UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors

Cell, 2014-02, Vol.156 (4), p.744-758

2014

Volltextzugriff (PDF)

Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (3), p.1107-1117

2013

Volltextzugriff (PDF)

1466 Galectin-1 orchestrates a hierarchical tumor to stromal extracellular vesicles system that fosters immune suppression

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1630-A1630

2023

Volltextzugriff (PDF)

Clinical relevance of galectin-1 expression in non-small cell lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2014-04, Vol.84 (1), p.73-78

2014

Volltextzugriff (PDF)

Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells

Molecular and Cellular Biology, 2005-06, Vol.25 (12), p.4826-4840

2005

Volltextzugriff (PDF)

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression

The Journal of experimental medicine, 2020-02, Vol.217 (2)

2020

Volltextzugriff (PDF)

Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings

IUBMB life, 2010-01, Vol.62 (1), p.1-13

2010

Volltextzugriff (PDF)

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer

Expert opinion on biological therapy, 2008-01, Vol.8 (1), p.45-57

2008

Volltextzugriff (PDF)

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity

Oncogene, 2004-07, Vol.23 (30), p.5161-5174

2004

Volltextzugriff (PDF)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells

Oncogene, 2001-01, Vol.20 (1), p.34-47

2001

Volltextzugriff (PDF)

Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells

Molecular and Cellular Biology, 2003-02, Vol.23 (3), p.1095-1111

2003

Volltextzugriff (PDF)

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer

Cancer cell, 2018-02, Vol.33 (2), p.155-157

2018

Volltextzugriff (PDF)

Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8 + regulatory T cells

Proceedings of the National Academy of Sciences - PNAS, 2021-05, Vol.118 (21), p.1

2021

Volltextzugriff (PDF)

Reprogramming the tumor metastasis cascade by targeting galectin-driven networks

Biochemical journal, 2021-02, Vol.478 (3), p.597-617

2021

Volltextzugriff (PDF)

Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells

Oncogene, 2023-10, Vol.42 (41), p.3087-3087

2023

Volltextzugriff (PDF)

Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation

Cancer cell, 2015-01, Vol.27 (1), p.27-40

2015

Volltextzugriff (PDF)

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10

Nature immunology, 2009-09, Vol.10 (9), p.981-991

2009

Volltextzugriff (PDF)

Abstract 1573: The progesterone analogue, Norgestrel, impairs tumor immunity and promotes metastatic breast cancer progression

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1573-1573

2016

Volltextzugriff (PDF)

Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity

Cancer research (Chicago, Ill.), 2021-03, Vol.81 (5), p.1375-1387

2021

Volltextzugriff (PDF)

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

The Journal of experimental medicine, 2012-10, Vol.209 (11), p.1985-2000

2012

Volltextzugriff (PDF)

Abstract 1840: Glycosylation of HER2+ human breast cancer cells control sensitivity to trastuzumab

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1840-1840

2018

Volltextzugriff (PDF)

A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins

Glycobiology (Oxford), 2023-12, Vol.33 (11), p.855-860

2023

Volltextzugriff (PDF)

Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments

International journal of cancer, 2012-09, Vol.131 (5), p.1131-1141

2012

Volltextzugriff (PDF)

Abstract 2959: Changes in the tumor stroma after MFP treatment in a MPA-induced murine mammary carcinoma model

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2959-2959

2017

Volltextzugriff (PDF)

Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis

Methods in molecular biology (Clifton, N.J.), 2022, Vol.2442, p.635

2022

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(79)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors

Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease

1466 Galectin-1 orchestrates a hierarchical tumor to stromal extracellular vesicles system that fosters immune suppression

Clinical relevance of galectin-1 expression in non-small cell lung cancer patients

Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression

Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells

Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer

Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8 + regulatory T cells

Reprogramming the tumor metastasis cascade by targeting galectin-driven networks

Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells

Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10

Abstract 1573: The progesterone analogue, Norgestrel, impairs tumor immunity and promotes metastatic breast cancer progression

Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

Abstract 1840: Glycosylation of HER2+ human breast cancer cells control sensitivity to trastuzumab

A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins

Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments

Abstract 2959: Changes in the tumor stroma after MFP treatment in a MPA-induced murine mammary carcinoma model

Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis

Suchergebnisse filtern